Randolph Seth Watnick, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombospondin 1 | 9 | 2022 | 257 | 2.580 |
Why?
|
Saposins | 2 | 2016 | 22 | 0.850 |
Why?
|
Neovascularization, Pathologic | 8 | 2014 | 2635 | 0.510 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 2014 | 6 | 0.460 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3939 | 0.460 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 391 | 0.440 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 489 | 0.380 |
Why?
|
Neoplasm Metastasis | 3 | 2014 | 4921 | 0.380 |
Why?
|
Paracrine Communication | 2 | 2009 | 278 | 0.360 |
Why?
|
Endocrine Cells | 1 | 2009 | 9 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2018 | 3520 | 0.330 |
Why?
|
Peptide Elongation Factors | 2 | 1999 | 60 | 0.320 |
Why?
|
Fibroblasts | 3 | 2014 | 4177 | 0.310 |
Why?
|
Viral Proteins | 4 | 2004 | 1802 | 0.300 |
Why?
|
Stromal Cells | 2 | 2012 | 1337 | 0.290 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 2952 | 0.250 |
Why?
|
ras Proteins | 2 | 2014 | 1058 | 0.220 |
Why?
|
Neoplasms | 4 | 2022 | 22385 | 0.220 |
Why?
|
Trypsinogen | 1 | 2022 | 84 | 0.210 |
Why?
|
Epithelial Cells | 2 | 2014 | 3695 | 0.210 |
Why?
|
Trypsin | 1 | 2022 | 491 | 0.200 |
Why?
|
Bacteriophage lambda | 2 | 1999 | 142 | 0.190 |
Why?
|
Terminator Regions, Genetic | 1 | 2000 | 26 | 0.180 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4907 | 0.160 |
Why?
|
Zinc | 2 | 2000 | 677 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 550 | 0.160 |
Why?
|
Coliphages | 1 | 1998 | 121 | 0.150 |
Why?
|
Tryptophan | 1 | 2000 | 482 | 0.150 |
Why?
|
Transcription, Genetic | 3 | 2000 | 7599 | 0.140 |
Why?
|
Hormones | 2 | 2012 | 870 | 0.140 |
Why?
|
Bacteriophages | 1 | 2000 | 382 | 0.130 |
Why?
|
Cyclization | 1 | 2016 | 59 | 0.130 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 861 | 0.130 |
Why?
|
Down-Regulation | 2 | 2014 | 2940 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1998 | 435 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2012 | 595 | 0.120 |
Why?
|
Transcription Factors | 3 | 2000 | 12166 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 214 | 0.120 |
Why?
|
Pneumonectomy | 2 | 2018 | 1158 | 0.120 |
Why?
|
Plasminogen Activator Inhibitor 2 | 1 | 2014 | 19 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.110 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 182 | 0.110 |
Why?
|
Cell Proliferation | 5 | 2018 | 10478 | 0.110 |
Why?
|
DNA, Viral | 1 | 1999 | 2205 | 0.100 |
Why?
|
Skin Pigmentation | 1 | 2014 | 278 | 0.100 |
Why?
|
Cell Line, Tumor | 7 | 2016 | 17135 | 0.100 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2012 | 67 | 0.100 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 606 | 0.100 |
Why?
|
Antigens, Ly | 1 | 2013 | 296 | 0.100 |
Why?
|
Megakaryocytes | 1 | 2015 | 571 | 0.090 |
Why?
|
Liposarcoma | 1 | 2014 | 289 | 0.090 |
Why?
|
Melanocytes | 1 | 2014 | 508 | 0.090 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11221 | 0.090 |
Why?
|
Heparin | 1 | 2018 | 1636 | 0.090 |
Why?
|
Retinoblastoma Protein | 1 | 2014 | 673 | 0.090 |
Why?
|
Cell Death | 1 | 2016 | 1682 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2884 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 393 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3731 | 0.090 |
Why?
|
Templates, Genetic | 2 | 2000 | 188 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 22355 | 0.080 |
Why?
|
Lung | 2 | 2018 | 10089 | 0.080 |
Why?
|
Amino Acids | 1 | 2016 | 1716 | 0.080 |
Why?
|
Cell Survival | 2 | 2018 | 5792 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2012 | 506 | 0.080 |
Why?
|
Escherichia coli | 2 | 1999 | 4211 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 1998 | 1883 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 23631 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2414 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 1999 | 3838 | 0.070 |
Why?
|
Transcriptional Elongation Factors | 2 | 1999 | 167 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3617 | 0.070 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 1999 | 366 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6350 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2004 | 12805 | 0.060 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2008 | 617 | 0.060 |
Why?
|
Cell Communication | 1 | 2012 | 1660 | 0.060 |
Why?
|
Blood Platelets | 1 | 2015 | 2476 | 0.060 |
Why?
|
Organ Specificity | 1 | 2009 | 1967 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3633 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2014 | 19022 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2009 | 998 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13423 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2846 | 0.050 |
Why?
|
Protein Binding | 3 | 2000 | 9343 | 0.050 |
Why?
|
Mice | 10 | 2018 | 82017 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2000 | 17626 | 0.050 |
Why?
|
Burkitt Lymphoma | 1 | 2004 | 337 | 0.050 |
Why?
|
Humans | 17 | 2022 | 768393 | 0.050 |
Why?
|
Animals | 11 | 2018 | 169337 | 0.050 |
Why?
|
Escherichia coli Proteins | 2 | 1999 | 1057 | 0.050 |
Why?
|
Mice, SCID | 3 | 2014 | 2632 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 867 | 0.050 |
Why?
|
rho GTP-Binding Proteins | 1 | 2003 | 279 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 750 | 0.050 |
Why?
|
rho-Associated Kinases | 1 | 2003 | 286 | 0.050 |
Why?
|
Cell Transplantation | 1 | 2003 | 475 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 674 | 0.040 |
Why?
|
RNA, Viral | 2 | 1999 | 2866 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 2003 | 0.040 |
Why?
|
Genes, ras | 1 | 2003 | 665 | 0.040 |
Why?
|
Phenanthrolines | 1 | 1999 | 49 | 0.040 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2394 | 0.040 |
Why?
|
Dithiothreitol | 1 | 1999 | 94 | 0.040 |
Why?
|
Osteosarcoma | 1 | 2006 | 911 | 0.040 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
Azides | 1 | 1999 | 120 | 0.040 |
Why?
|
Histidine | 1 | 2000 | 302 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2004 | 1082 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2003 | 1064 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2018 | 152 | 0.040 |
Why?
|
DNA, Single-Stranded | 1 | 2000 | 351 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2012 | 8634 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 650 | 0.040 |
Why?
|
Hirudins | 1 | 2018 | 179 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2003 | 3587 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2146 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1999 | 692 | 0.030 |
Why?
|
Disease Progression | 1 | 2014 | 13646 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18362 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1658 | 0.030 |
Why?
|
DNA Primers | 1 | 2000 | 2825 | 0.030 |
Why?
|
Cyclohexanes | 1 | 2015 | 152 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 560 | 0.030 |
Why?
|
Pigmentation | 1 | 2014 | 143 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1696 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3813 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 491 | 0.030 |
Why?
|
Cell Line | 2 | 2008 | 15597 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2014 | 254 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2890 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1141 | 0.030 |
Why?
|
NF-kappa B | 2 | 2014 | 2489 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2012 | 125 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1371 | 0.020 |
Why?
|
Proteoglycans | 1 | 2014 | 807 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3526 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 835 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.020 |
Why?
|
Microcirculation | 1 | 2014 | 1282 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3781 | 0.020 |
Why?
|
Binding Sites | 1 | 1998 | 6017 | 0.020 |
Why?
|
Base Sequence | 1 | 2000 | 12422 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6510 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6406 | 0.020 |
Why?
|
Pyridines | 1 | 1999 | 2889 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1194 | 0.020 |
Why?
|
Male | 5 | 2018 | 364902 | 0.020 |
Why?
|
Models, Biological | 1 | 2003 | 9493 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10776 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6234 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5151 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4588 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 612 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21162 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5037 | 0.010 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 158 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3794 | 0.010 |
Why?
|
Immunoblotting | 1 | 2006 | 1647 | 0.010 |
Why?
|
Phenotype | 2 | 2014 | 16721 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2014 | 3587 | 0.010 |
Why?
|
Female | 3 | 2016 | 397089 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7598 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9562 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6132 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40272 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9510 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11120 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2008 | 7880 | 0.010 |
Why?
|